MHCII restriction demonstrates B cells have very limited capacity to activate tumour-specific CD4+ T cells in vivo

Volume 13, Issue 1, December 2024 .

Source: OncoImmunology - December 11, 2023 Category: Cancer & Oncology Authors: Thomas V. GuyAlexandra M. TerryHelen M. McGuireElena ShklovskayaBarbara Fazekas de St Grotha T cell Biology Program, Centenary Institute of Cancer Medicine and Cell Biology, Sydney, NSW, Australiab Pillai Labratory, Ragon Institute of MGH, Harvard and MIT Source Type: research